Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Firms Share NDI Notification Tips And Experts Reveal Common Pitfalls

This article was originally published in The Tan Sheet

Executive Summary

Early and frequent communication with FDA is key to earning an elusive FDA acceptance of a new dietary ingredient notification on the first try, an agriculture-tech firm executive says
Advertisement

Related Content

Artful Approach Improves NDI Notifications’ Chances At FDA
Artful Approach Improves NDI Notifications’ Chances At FDA
GRAS Path Draws Interest As New Dietary Ingredient Alternative, But Carries Challenges
GRAS Path Draws Interest As New Dietary Ingredient Alternative, But Carries Challenges
FDA "Not Happy" Without NDI Guidance, Works To Improve Acceptance Rates
Ovos Plots Vivimind Cognitive Supplement Launch, Awaits FDA Reply
Economic Pressures Push More Consumers To Buy Supplements - CRN Survey
Salmonella Problem Stirs Food Safety Bills, Hearing From Energy & Commerce
NDI Notification Guidance To Assist Puzzled Industry Could Emerge In 2009
NDI Notification Guidance To Assist Puzzled Industry Could Emerge In 2009

Topics

Advertisement
UsernamePublicRestriction

Register

PS103704

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel